SEC Comment Letter for Nautilus Biotechnology, Inc. (NAUT) (CIK 0001808805) (NAUT) — May 14, 2020
Nautilus Biotechnology, Inc. (NAUT) (CIK 0001808805)
Date: May 14, 2020 · CIK: 0001808805 · Accession: 0000000000-20-004282
AI Filing Summary & Sentiment
Letter
United States securities and exchange commission logo May 14, 2020 Adam Stone Chief Executive Officer ARYA Sciences Acquisition Corp III 51 Astor Place, 10th Floor New York, New York 10003 Re:ARYA Sciences Acquisition Corp III Draft Registration Statement on Form S-1 Submitted April 17, 2020 CIK 0001808805 Dear Mr. Stone: We have reviewed your draft registration statement and have the following comment. In our comment, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by providing the requested information and either submitting an amended draft registration statement or publicly filing your registration statement on EDGAR. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing the information you provide in response to this comment and your amended draft registration statement or filed registration statement, we may have additional comments. Draft Registration Statement on Form S-1 filed April 17, 2020 Description of Securities Founder Shares, page 112 1.We note your disclosure on page 112 that holders of your Class B common stock will have the right to elect all of your directors prior to your initial business combination. Please disclose whether the company will be a controlled company as defined under Nasdaq's rules and discuss the the corporate governance exemptions that Nasdaq provides to a controlled company. If applicable, include risk factor disclosure.
FirstName LastNameAdam Stone Comapany NameARYA Sciences Acquisition Corp III May 14, 2020 Page 2 FirstName LastName Adam Stone ARYA Sciences Acquisition Corp III May 14, 2020 Page 2 You may contact Paul Cline at 202-551-3851 or Kristina Marrone at 202-551-3429 if you have questions regarding comments on the financial statements and related matters. Please contact Michael Killoy at 202-551-7576 or Pam Long at 202-551-3765 with any other questions. Sincerely, Division of Corporation Finance Office of Real Estate & Construction
Show Raw Text
United States securities and exchange commission logo
May 14, 2020
Adam Stone
Chief Executive Officer
ARYA Sciences Acquisition Corp III
51 Astor Place, 10th Floor
New York, New York 10003
Re:ARYA Sciences Acquisition Corp III
Draft Registration Statement on Form S-1
Submitted April 17, 2020
CIK 0001808805
Dear Mr. Stone:
We have reviewed your draft registration statement and have the following comment. In
our comment, we may ask you to provide us with information so we may better understand your
disclosure.
Please respond to this letter by providing the requested information and either submitting
an amended draft registration statement or publicly filing your registration statement on
EDGAR. If you do not believe our comment applies to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.
After reviewing the information you provide in response to this comment and your
amended draft registration statement or filed registration statement, we may have additional
comments.
Draft Registration Statement on Form S-1 filed April 17, 2020
Description of Securities
Founder Shares, page 112
1.We note your disclosure on page 112 that holders of your Class B common stock will
have the right to elect all of your directors prior to your initial business combination.
Please disclose whether the company will be a controlled company as defined under
Nasdaq's rules and discuss the the corporate governance exemptions that Nasdaq provides
to a controlled company. If applicable, include risk factor disclosure.
FirstName LastNameAdam Stone
Comapany NameARYA Sciences Acquisition Corp III
May 14, 2020 Page 2
FirstName LastName
Adam Stone
ARYA Sciences Acquisition Corp III
May 14, 2020
Page 2
You may contact Paul Cline at 202-551-3851 or Kristina Marrone at 202-551-3429 if you
have questions regarding comments on the financial statements and related matters. Please
contact Michael Killoy at 202-551-7576 or Pam Long at 202-551-3765 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Real Estate & Construction